Integra Therapeutics at ‘CRISPR News Medicine’

CRISPR News Medicine publishes an article entitled Adaptation of jumping gene boosts CRISPR-Cas gene-writing technology to new heights about new FiCAT platform developed by Integra Therapeutics. By Henri van de Vrugt